Stephanus Julia A
CHIEF COMMERCIAL OFFICER at ARATANA THERAPEUTICS, INC.
- Sold, on record
- $453k
- Dollars the filings state
- Form 4 sales
- 4
- Latest Jun 28, 2016
- Form 144 notices
- 0
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- ARATANA THERAPEUTICS, INC.CHIEF COMMERCIAL OFFICER
Sales by reason
0
Routine
0
Plan not stated
0
No plan
0
Unusual
Form 4 sales per month, last 12 months.
Timeline
- 1 Form 4 sale ARATANA THERAPEUTICS, INC.Plan not statedJun 16, 2014 2014
Sold 8,000 shares at $13.90 ($111k)
Stephanus Julia A, CHIEF COMMERCIAL OFFICER
Sold 6.2% of holdings ($1.8M position)121,967 shares leftFirst sale on recordFiling
- 2 Form 4 sale ARATANA THERAPEUTICS, INC.Plan not statedJul 3, 2014 +17 days
Sold 2,000 shares at $17.33 ($35k)
Stephanus Julia A, CHIEF COMMERCIAL OFFICER
Sold 1.6% of holdings ($2.1M position)119,679 shares leftFiling
- 3 Form 4 sale ARATANA THERAPEUTICS, INC.Plan not statedJan 13, 2015 +194 days
Sold 6,300 shares at $19.00 ($120k)
Stephanus Julia A, CHIEF COMMERCIAL OFFICER
Sold 5.3% of holdings ($2.3M position)112,803 shares leftFiling
- 4 Form 4 sale ARATANA THERAPEUTICS, INC.Plan not statedJun 28, 2016 +532 days
Sold 30,000 shares at $6.25 ($188k)
Stephanus Julia A, CHIEF COMMERCIAL OFFICER
Sold 19% of holdings ($984k position)127,503 shares leftFiling
Every transaction
Loading transactions…
Sales and notices (4)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Jun 28, 2016 | Jun 28, 2016 | ARATANA THERAPEUTICS, INC. | CHIEF COMMERCIAL OFFICER | Form 4 sale | 30,000 | $188k | 19.0% | Plan not stated | SEC |
| Jan 13, 2015 | Jan 13, 2015 | ARATANA THERAPEUTICS, INC. | CHIEF COMMERCIAL OFFICER | Form 4 sale | 6,300 | $120k | 5.3% | Plan not stated | SEC |
| Jul 3, 2014 | Jul 3, 2014 | ARATANA THERAPEUTICS, INC. | CHIEF COMMERCIAL OFFICER | Form 4 sale | 2,000 | $35k | 1.6% | Plan not stated | SEC |
| Jun 16, 2014 | Jun 16, 2014 | ARATANA THERAPEUTICS, INC. | CHIEF COMMERCIAL OFFICER | Form 4 sale | 8,000 | $111k | 6.2% | Plan not stated | SEC |